As expected, a history of smoking or active smoking was present in a large percentage (76%) of all lung cancer subjects. Clinically relevant comorbidities were found in 62% of the subjects, in particular COPD (22%), arterial hypertension (42%), compensated chronic heart failure (7%) and coronary heart disease (CHD) as well as chronic atrial fibrillation (20%). Patient characteristics are shown in